Health
C.D.C. Site Restores Some Purged Files After ‘Gender Ideology’ Ban Outcry

On Friday, the Centers for Disease Control and Prevention purged from its website thousands of pages that included terms such as “transgender,” “L.G.B.T.” and “pregnant person,” to comply with an executive order barring any material that promoted “gender ideology.”
By Monday, some of the pages had reappeared, in part in response to intense media coverage, backlash from the scientific community and concern for the public’s health, according to a senior official with knowledge of the matter.
The purge had also swept up vaccine information statements, which must be given to patients before they can be immunized; guidelines for contraception; and several pages on how race and racism affect health outcomes. Also removed was a database containing 20 years of H.I.V. data that doctors rely on to determine whether a pregnant woman lives in an area of high H.I.V. prevalence and should be tested for the virus in her third trimester.
Some of these resources were also reinstated, but the return was not entirely smooth. Charts and tables in the H.I.V. database could be reached through a Google search, for instance, but the C.D.C.’s own portal remained broken.
C.D.C. employees are “fully and completely implementing the executive order,” said a senior official who spoke on condition of anonymity for fear of retaliation. But “historical data, articles, and clinical guidelines continue to be available,” the official said. “That essentially is how this is being applied.”
The shake-up accompanied two other directives also aimed at expunging information on certain topics. C.D.C. scientists were ordered late on Friday to withdraw any pending publications, at any scientific journal, that mention the forbidden terms, according to an email viewed by The New York Times.
Separately, a directive prohibiting C.D.C. employees from holding scientific meetings or communicating with other organizations or the public was indefinitely extended on Saturday, when it was expected to lapse, according to another email obtained by The Times.
“I am very fearful and I am very angry about what is happening right now,” said Dr. Ina Park, an expert in H.I.V. and other sexually transmitted infections at the University of California, San Francisco.
The directive also targeted pages on other government websites, including a webpage on Section 1557 of the Affordable Care Act, under the aegis of the Health and Human Services Department. That provision forbids “discrimination on the basis of race, color, national origin, age, disability, or sex (including pregnancy, sexual orientation, gender identity, and sex characteristics), in covered health programs or activities.” It, too, was back online on Monday.
The C.D.C.’s recommendations are the bedrock of clinical practice in the United States. Every hospital’s procedural manuals are filled with the agency’s documents, and clinicians regularly refer to the recommendations, on the website or through the agency’s app.
Now, however, searching for some terms leads to a dead link or to pages that have been stripped of key details, or the search yields a suggestion to explore another topic instead. For instance, a search for the word “abortion” suggests that the user “also try: adoption.”
Some pages — for instance, those on transgender health — were expected to remain absent because they might promote “gender ideology.”
“I have no idea what that term means,” said Dr. Richard Besser, who served as acting director of the C.D.C. in 2009.
“We’re not talking here about ideology — we’re talking about public health,” he added. “We’re talking about people whose lives are being put at risk.”
The disappearance of the pages is already affecting medical care. In Washington State, Dr. Tim Menza, a medical director for King County’s sexual health clinic, worried that hard-won progress against early syphilis in gay and bisexual men would be lost.
Dr. Jessica Weyer, an obstetrician-gynecologist in Concord, N.H., said she could not guide her patients’ choice of contraception without access to the complex eligibility criteria. For instance, the guidelines for birth control include recommendations for patients with various medical conditions. They also list drug interactions that must be taken into account and give providers information on newer methods like vaginal rings.
“If a patient has high blood pressure or migraine headaches, I need to know what’s safe for her,” Dr. Alison Stuebe, an obstetrician-gynecologist in North Carolina, said.
The C.D.C. website is ostensibly being altered to comply with Mr. Trump’s executive orders on diversity, equity, inclusion, accessibility and “defending women.” But vaccine information statements and contraception guidelines are unrelated to those orders, Dr. Weyer said.
“This just seems like a purposeful removal of important information providing safe contraception, which I view as terrifying,” she said. “It sounds like they want to control women, not defend women.”
Although the executive orders did not mention race, several resources on structural racism and health disparities in certain communities also disappeared on Friday.
In the United States, race and ethnicity are strongly linked to health. Black and Native American women are two to three times as likely as white women to die during pregnancy and after childbirth, and their babies face roughly twice the risk of dying before their first birthday. Diabetes, obesity and other chronic diseases are also much more prevalent, and life expectancy is lower, among racial and ethnic minority groups.
Information on racial disparities is crucial for helping health care providers to focus on the groups most at risk, said Linda Goler Blount, president of the Women’s Black Health Imperative, an advocacy group. During the Covid pandemic, she noted, health researchers discovered that pulse oximeter devices, which measure blood oxygen levels, “didn’t work on people with dark skin.” That disparity might have contributed to higher death rates among communities of color.
“If we can’t collect data by race, ethnic identity and gender identity, we’re going to see mortality rates increase,” Ms. Blount said.
Mr. Trump’s orders purged more than 8,000 web pages across more than a dozen U.S. government websites. In some cases, the executive orders also targeted the work of private citizens.
A memo to the federal Agency for Healthcare Research and Quality, which publishes papers from both government and academic researchers, gave employees until 5 p.m. on Friday to scrub the agency’s publication, Patient Safety Network, of terms including “transgender,” “nonbinary,” “L.G.B.T.” and “gender identity.”
Among the roughly 20 research papers that were taken down was one from 2022 detailing how clinicians can better identify emergency room patients at risk of suicide. The paper’s lead author, Dr. Gordon Schiff, is the director of quality and safety for the Harvard Medical School Center for Primary Care; he is not a government scientist. The paper was flagged for a single line: “High risk groups include male sex, being young, veterans, Indigenous tribes, lesbian, gay, bisexual, transgender, queer/questioning (L.G.B.T.Q.).”
Dr. Schiff said he was shocked by the new administration’s “extreme censorship.” “This whole idea that the risk factors or commentary should be based on political ideology rather than data and truth is a pretty scary prospect,” he said.
Some experts are exploring the legality of the administration’s deleting content from federal websites and papers written by C.D.C. scientists. But in the case of Dr. Schiff’s paper, the administration clearly crossed the line, said Larry Gostin, director of the World Health Organization Center on Global Health Law.
“To me, that’s classic viewpoint censorship in violation of the First Amendment,” Mr. Gostin said.
“While the administration may be able to silence government health officials carrying out their official duties, it cannot drag private scientists into its web of censorship,” he added. “And all that censorship for expressing a single word with which the government objects.”

Health
Is Low-Fat or Low-Carb Better for Weight Loss? Experts Settle the Debate

Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Health
Weight loss, diabetes drugs can cause mood changes: What to know about behavioral side effects

GLP-1 receptor agonists (GLP-1 RAs), medications that help control type 2 diabetes and obesity, can have a profound impact on physical wellness – but what about mental health?
Some examples of these medications include semaglutides, such as Ozempic and Wegovy, and liraglutide, like Victoza and Saxenda.
Various studies have pointed toward GLP-1 RAs causing mental health complications, such as anxiety and depression.
WEIGHT-LOSS DRUGS’ IMPACT ON CANCER RISK REVEALED IN NEW STUDY
The National Institutes of Health (NIH) published research in June 2024 that considered the correlation between semaglutide therapy and “exacerbating mood disturbances.”
The study highlighted the association of negative mood changes in patients with type 2 diabetes with a history of depression, warning healthcare providers to be aware of this “potential risk.”
Studies have debated the correlation between GLP-1 RA drugs and mood changes. (iStock)
But a more recent study, published in the journal Diabetes, Obesity and Metabolism, suggested that these mood changes were linked to genetic variations across diverse populations and ancestries within the U.K. Biobank.
While GLP-1 RA variants had “consistent cardiometabolic effects” across all groups, the researchers said the negative impacts on mental health were “more varied,” concluding that any behavioral changes are “likely not acting directly through [the medications].”
SEMAGLUTIDE FOUND TO HAVE SHOCKING BENEFIT FOR LIVER DISEASE PATIENTS IN NEW STUDY
Doctors weigh in on medications and mood
Dr. Brett Osborn, a Florida neurosurgeon who often prescribes GLP-1 RAs to his patients, believes that there is “no consistent causal relationship” between these medications and mental illness.
“Researchers assayed genetic markers across almost half a million people from different backgrounds in search of a link between the gene behind GLP-1 receptors and mental health problems like depression, anxiety or suicidal ideation — and they didn’t find it,” he summarized.

GLP-1 receptor agonists have been linked to mood changes, patients and doctors have reported. (iStock)
People who are obese or battling type 2 diabetes are “often already depressed” without the medication, the doctor pointed out.
“These conditions take a toll – physically, emotionally and socially,” he said. “So, yes, a large portion of patients starting GLP-1 drugs are already dealing with mental health struggles. But that’s not because of the drug — that’s because of the disease.”
HERE’S WHY BELLY FAT IS MORE COMMON AS WE AGE, AND 3 WAYS TO PREVENT IT
Once these individuals begin dropping weight, blood sugar stabilizes and energy improves, which usually lifts their mood as well.
“GLP-1 drugs help people reclaim their health,” Osborn noted. “They reduce inflammation. They lower blood sugar. They shrink waistlines.”
“And when people look and feel better, when their bodies finally start working for them instead of against them, they often smile more, not less.”

“GLP-1 drugs help people reclaim their health,” one doctor said. “And when people look and feel better, when their bodies finally start working for them instead of against them, they often smile more, not less.” (iStock)
Dr. Muhammad Ghanem, a bariatric surgeon at Orlando Health Weight Loss and Bariatric Surgery Institute, shared in a separate interview with Fox News Digital that while some of his patients have reported mood changes, others “don’t have that at all.”
FIRST GLP-1 PILL FOR WEIGHT LOSS, DIABETES SHOWS SUCCESS IN LATE-PHASE TRIAL
“Depression or mood changes are very common regardless, especially nowadays, and so it’s hard to [determine] whether this is related to the GLP-1 agonist medications, or whether it just happens to be that they started suffering from these after they started that medication,” he said.
“It’s really hard to tell whether it’s a personality change that can happen because of weight loss or if it’s a side effect because of mood changes,” he added. “I don’t think we have enough data to reach that conclusion yet.”

For those who are interested in GLP-1 RA medications or are experiencing mood changes while taking them, an expert stressed the importance of keeping in close contact with medical providers. (iStock)
Patients who lose weight with GLP-1 RAs can experience a “big boost” in confidence, as well as a change in personality and even relationships, according to Ghanem.
“It really depends on the person and the support system they have,” he said. “You need proper, randomized controlled trials to reach a conclusion, and better studies to determine whether this is related to the medication itself or just weight loss.”
“It’s important for all doctors who prescribe these drugs to be aware and check the patient’s history.”
For those who are interested in these medications or are experiencing mood changes while taking them, the surgeon stressed the importance of keeping in close contact with medical providers.
“Just like any other medication, they can have potential side effects,” he said.
Ghanem recommended seeking out professionals and practices who take a “holistic approach” to weight loss, offering mental health support in addition to medication.
Dr. Brunilda Nazario, MD, chief physician editor of medical affairs at WebMD, told Fox News Digital that “obesity is complicated.”
“Obesity specialists … are cautiously excited about how well these drugs work,” she said.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“With current studies showing conflicting results on mood disorders and the use of GLP-1 drugs, it’s important for all doctors who prescribe these drugs to be aware and check the patient’s history before prescribing [them].”

“Don’t be afraid to ask for help if you feel something is not right — your health depends on it,” one expert suggested. (iStock)
Nazario stressed that it’s “vital” for GLP-1 RA users to listen to their bodies, urging them to pay attention to their feelings and know the symptoms of mood disorders.
“Don’t be afraid to ask for help if you feel something is not right — your health depends on it,” he added.
For more Health articles, visit www.foxnews.com/health
Nazario noted that GLP-1 RAs can affect mood in many different ways.
“They are not all negative — they have the potential to improve mood as well,” she said. “Just seeing great results can boost self-esteem, confidence and body image.”
Health
How to Access GLP-1 Medications After FDA New Rules | Woman's World

Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
-
Austin, TX1 week ago
Best Austin Salads – 15 Food Places For Good Greens!
-
Technology1 week ago
Netflix is removing Black Mirror: Bandersnatch
-
World1 week ago
The Take: Can India and Pakistan avoid a fourth war over Kashmir?
-
News1 week ago
Reincarnated by A.I., Arizona Man Forgives His Killer at Sentencing
-
News1 week ago
Who is the new Pope Leo XIV and what are his views?
-
News1 week ago
Efforts Grow to Thwart mRNA Therapies as RFK Jr. Pushes Vaccine Wariness
-
Entertainment1 week ago
Review: 'Forever' is a sweet ode to first love (and L.A.) based on Judy Blume's novel
-
Politics1 week ago
Department of Justice opens criminal investigation into NY AG Letitia James